private:neurovista
|
84500
|
May 30th, 2019 12:00AM
|
NeuroVista Corporation
|
524
|
5.00
|
Open
|
Medical Devices
|
May 30th, 2019 01:46PM
|
May 30th, 2019 01:46PM
|
NeuroVista Corporation was an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
|
Open
|
Epilepsy, Medical Device Research and Development
|
Open
|
100 Fourth AVE N, STE 600
|
Seattle
|
WA
|
US
|
|
|
NeuroVista
|
|
Health Care Equipment & Services
|
private:neurovista
|
84500
|
Feb 17th, 2018 12:00AM
|
NeuroVista Corporation
|
501
|
5.00
|
Open
|
Medical Devices
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
NeuroVista Corporation was an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
|
|
|
|
|
|
|
|
|
|
NeuroVista
|
|
Health Care Equipment & Services
|
private:neurovista
|
84500
|
Feb 16th, 2018 12:00AM
|
NeuroVista Corporation
|
501
|
5.00
|
Open
|
Medical Devices
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
NeuroVista Corporation was an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
|
|
|
|
|
|
|
|
|
|
NeuroVista
|
|
Health Care Equipment & Services
|
private:neurovista
|
84500
|
Feb 15th, 2018 12:00AM
|
NeuroVista Corporation
|
501
|
5.00
|
Open
|
Medical Devices
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
NeuroVista Corporation was an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
|
|
|
|
|
|
|
|
|
|
NeuroVista
|
|
Health Care Equipment & Services
|
private:neurovista
|
84500
|
Feb 14th, 2018 12:00AM
|
NeuroVista Corporation
|
501
|
5.00
|
Open
|
Medical Devices
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
NeuroVista Corporation was an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
|
|
|
|
|
|
|
|
|
|
NeuroVista
|
|
Health Care Equipment & Services
|
private:neurovista
|
84500
|
Feb 13th, 2018 12:00AM
|
NeuroVista Corporation
|
501
|
5.00
|
Open
|
Medical Devices
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
NeuroVista Corporation was an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
|
|
|
|
|
|
|
|
|
|
NeuroVista
|
|
Health Care Equipment & Services
|
private:neurovista
|
84500
|
Feb 12th, 2018 12:00AM
|
NeuroVista Corporation
|
501
|
5.00
|
Open
|
Medical Devices
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
NeuroVista Corporation was an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
|
|
|
|
|
|
|
|
|
|
NeuroVista
|
|
Health Care Equipment & Services
|
private:neurovista
|
84500
|
Feb 11th, 2018 12:00AM
|
NeuroVista Corporation
|
501
|
5.00
|
Open
|
Medical Devices
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
NeuroVista Corporation was an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
|
|
|
|
|
|
|
|
|
|
NeuroVista
|
|
Health Care Equipment & Services
|
private:neurovista
|
84500
|
Feb 10th, 2018 12:00AM
|
NeuroVista Corporation
|
501
|
5.00
|
Open
|
Medical Devices
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
NeuroVista Corporation was an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
|
|
|
|
|
|
|
|
|
|
NeuroVista
|
|
Health Care Equipment & Services
|
private:neurovista
|
84500
|
Feb 9th, 2018 12:00AM
|
NeuroVista Corporation
|
501
|
5.00
|
Open
|
Medical Devices
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
NeuroVista Corporation was an early-stage medical device company pioneering new technologies that will revolutionize the management and treatment of epilepsy, a neurological condition affecting approximately 1% of the U.S. population—more than Parkinson's disease, multiple sclerosis and Lou Gehrig's disease combined.
|
|
|
|
|
|
|
|
|
|
NeuroVista
|
|
Health Care Equipment & Services
|